Lanx®, Inc., a privately held medical device company focused on developing and commercializing innovative devices for spinal surgery, today announced the initial launch of its Durango™ Stand-Alone ALIF System (Durango), following 510(k) clearance in February. The announcement was made at the 2011 American Association of Neurological Surgeons (AANS) Annual Meeting, Denver, CO.
The Durango system is intended to treat degenerative disc disease at one or two levels from L2 to S1 through anterior lumbar interbody fusion (ALIF), and has been approved as a stand-alone implant when used with all four fixation screws. It is the first system on the market to offer multiple plate options, including a full plate, a zero-profile plate, and the first ever half plate with 15 degree angled screws for more challenging anatomies.
"The Durango system expands the breadth of our fusion portfolio, offering a reliable, integrated ALIF solution to meet the needs and preferences of surgeons and improve care for diverse patient anatomies," said Dan Gladney, Chief Executive Officer, Lanx. "After several successful cases, the new anchored cage continues to receive positive feedback regarding the versatility of its plate options and the system's ease of implantation."
The Durango system has been designed to improve stability and promote fusion, combining a PEEK OPTIMA® LT1 large footprint interbody spacer, a titanium anterior plate and four fixation screws. The system also includes a full set of specialized instrumentation and a one-step cover plate with a secure, center set screw to prevent screw back-out.